Weave Communications, Inc. (WEAV) AI Stock Analysis

NYSE: WEAVAI research summary: business, growth, valuation, analysts, bull and bear case.

WEAV AI stock analysis summary

AI Research

Weave Communications, Inc. (NYSE: WEAV) is a customer communications and engagement software provider serving small and medium-sized businesses. The company grew annual revenue to $239.0M in FY2025, generating $15.2M in free cash flow despite remaining net unprofitable. Over the trailing twelve months, revenue reached $257.8M while quarterly revenue grew 15.5% year-over-year.

Market cap
$595.3M
Revenue (TTM)
$257.8M
P/E
—
1Y return
13.3%
S&P 500 16.8%
Avg. target
$7.40
0.0% vs last close

Bull case

  • Free cash flow expanded to $15.2M in FY2025, marking three consecutive fiscal years of positive cash generation.
  • Gross margins increased from 57.4% in FY2021 to 72.1% in FY2025 as revenue reached $239.0M.
  • Balance sheet strength includes $78.5M in cash and short-term investments, supporting net cash of $27.1M as of June 30, 2026.

Bear case

  • The company posted a trailing twelve-month net loss with an operating margin of -6.2% and EPS of -$0.26.
  • Share count expanded 25.2% over a 5-year span, diluting existing equity holders.
  • Year-over-year revenue growth slowed from 45.0% in FY2021 to 17.0% in FY2025.

What Weave Communications does

Weave Communications, Inc. provides customer communications and engagement software solutions across the United States and Canada, specializing in serving small and medium-sized businesses. Its platform offers a suite of tools including a Customized Phone System, Weave Text Messaging, Weave Missed Call Text, and Weave Team for internal messaging. The company also delivers the Weave Mobile App, Weave Reviews, Weave Email Marketing, and Web Assistant Appointment Requests. Additionally, Weave provides specialized solutions such as Weave Payments for payment processing, Customer Insights for engagement, and Analytics for business performance analysis.

Growth and profitability

Revenue expanded from $115.9M in FY2021 to $239.0M in FY2025, supported by a 5-year revenue CAGR of 24.5%. Gross margin widened consistently from 57.4% in FY2021 to 72.1% in FY2025. Although operating margin remained negative, it improved from -43.5% to -12.1% over the same period, while net income improved from -$51.7M to -$28.1M. Diluted EPS reached $0.09 in FY2025. For the trailing twelve months ended June 30, 2026, revenue stood at $257.8M with an operating margin of -6.2% and EPS of -$0.26. Year-over-year quarterly revenue growth in the latest quarter was 15.5%.

WEAV income statement →

Balance sheet and cash flow

As of June 30, 2026, Weave held $78.5M in cash and short-term investments against $51.4M in total debt, resulting in net cash of $27.1M. The company reported a current ratio of 1.25, total assets of $208.6M, and shareholders' equity of $85.0M, resulting in a debt-to-equity ratio of 0.60. Operating cash flow grew to $17.5M in FY2025, up from $14.1M in FY2024. Capital expenditures were $2.4M in FY2025, leading to free cash flow of $15.2M. Share count increased 25.2% over 5 years.

WEAV balance sheet →

Valuation and performance

At $7.40 per share, Weave has a market cap of $595.3M and an enterprise value of $561.8M. The stock trades at a price-to-sales multiple of 2.3x and an EV-to-revenue multiple of 2.2x, below the median of its US-listed Healthcare peers at 4.1x price-to-sales. Its price-to-book ratio is 6.4x. Over the past year, WEAV gained 13.3%, trailing the S&P 500 (SPY) return of 16.8%, and the stock is down 2.5% year-to-date.

WEAV key metrics →

What analysts expect

Consensus coverage shows 4 Hold ratings, with 0 Strong Buy, 0 Buy, 0 Sell, and 0 Strong Sell ratings. The mean price target is $7.40, matching the last close of $7.40 (0.0% difference). For the fiscal year ending December 31, 2026, consensus estimates project revenue of $274.2M and EPS of $0.17. For FY2027, 4 analysts estimate revenue of $310.9M and EPS of $0.25. The company beat EPS estimates in 3 of the last 4 quarters, with next earnings scheduled for October 29, 2026.

WEAV forecast and price target →

Key risks and what to watch

  • Return on equity over the trailing twelve months was -25.1%, reflecting ongoing profitability challenges.
  • The stock carries a beta of 1.68, indicating substantially higher price volatility than the broader market.
  • Short interest represents 7.1% of the float as of October 16, 2026.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this WEAV AI stock analysis

This page is an AI-written research summary of Weave Communications, Inc. (WEAV). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: WEAV income statement, WEAV balance sheet, WEAV key metrics, WEAV analyst forecast, WEAV chart. See the WEAV stock overview for the latest quote and news.

WEAV AI stock analysis FAQ

Does Weave Communications pay a dividend?

No, Weave Communications does not pay a dividend. The company directs its capital toward business operations, research and development ($44.5M in FY2025), and capital expenditures ($2.4M in FY2025).

What are analysts projecting for Weave's earnings?

Analysts estimate EPS of $0.17 on revenue of $274.2M for the fiscal year ending December 31, 2026. For the following fiscal year, consensus models EPS of $0.25 on revenue of $310.9M.

How much debt does Weave Communications have?

As of June 30, 2026, Weave had $51.4M in total debt against $78.5M in cash and short-term investments, resulting in a net cash position of $27.1M and a debt-to-equity ratio of 0.60.

When is Weave's next earnings report?

Weave Communications is scheduled to report its next financial results on October 29, 2026.

More Healthcare AI stock analysis